稳心颗粒联合胺碘酮治疗冠心病心律失常患者的临床疗效
1资料与方法,2结果,3讨论
陈 颖稳心颗粒联合胺碘酮治疗冠心病心律失常患者的临床疗效
陈 颖
【摘要】目的 探讨稳心颗粒联合胺碘酮治疗冠心病心律失常患者的临床疗效。方法 选取2014年2月至2015年2月在阜新市第二人民医院接受药物治疗的冠心病心律失常患者88例为研究对象,应用随机双盲法将其分为对照组和观察组,各44例。对照组患者口服胺碘酮,观察组患者在对照组基础上口服稳心颗粒,比较两组患者的临床疗效以及不良反应发生情况。结果 观察组患者总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论 稳心颗粒联合胺碘酮治疗冠心病心律失常患者临床疗效明显,且不会增加药物的不良反应,发挥了良好的协同作用。
【关键词】稳心颗粒;胺碘酮;冠心病心律失常;疗效
【中图分类号】R541.7
【文献标志码】A
【文章编号】1673-5846(2015)10-0042-02
【Abstract】Objective To investigate the clinical effect of combined treatment of heart and heart particles in the treatment of coronary heart disease arrhythmia.Methods From February 2015 to February 2014,88 patients with coronary heart disease arrhythmia in our hospital were randomly divided into control group and observation group with 44 cases in each group.The control group was treated with amiodarone,and the observation group was treated with stable heart granules on the basis of the control group.The clinical efficacy and adverse reactions of the two groups were compared.Results The total effective rate of the observation group was significantly higher than that of the control group,the difference was statistically significant(P<0.05).Conclusion The clinical effect of combined treatment of cardiac arrhythmia in patients with coronary heart disease,and can not increase the adverse drug reactions. ......
您现在查看是摘要页,全文长 5474 字符。